# Pharma

China’s Biotech Vanguard: Breakthroughs in Lymphoma and Obesity Signal a Shift Toward Global Leadership

China is transitioning from a follower to a leader in biotech, evidenced by Lupin Pharmaceuticals' approval of the first 4th-gen BTK inhibitor and Hansoh Pharma's potent new weight-loss drug. These breakthroughs, supported by massive out-licensing deals with firms like Regeneron, demonstrate that Chinese innovation is now competitive on a global scale.